Ignite Creation Date:
2024-05-06 @ 2:52 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04457180
Status:
COMPLETED
Last Update Posted:
2022-10-26
First Post:
2020-06-30
Brief Title:
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Organization Data
Organization:
Jiangsu HengRui Medicine Co Ltd
Class:
INDUSTRY
Study ID:
HR-APTN-I-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jiangsu HengRui Medicine Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None